MediPharm Labs MEDIF stock analysis and why MediPharm Labs MEDIF stock moves up

A new Gilead book about peo­ple liv­ing with se­ri­ous dis­eases is writ­ten in the lit­er­al mar­gins of each page. Called “From the Mar­gins,” the dig­i­tal

A next-gen­er­a­tion GLP-1 can­di­date from Eli Lil­ly has out­done an old­er Lil­ly drug in a Phase 3 tri­al in­volv­ing Chi­nese pa­tients with di­a­betes, Lil­ly part­ner